Form 8-K - Current report:
SEC Accession No. 0001213900-20-009167
Filing Date
2020-04-14
Accepted
2020-04-14 15:45:31
Documents
5
Period of Report
2020-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea120625-8k_americanbri.htm 8-K 21843
2 FORM OF WARRANT ISSUED TO THE HOLDERS PURSUANT TO THE EXCHANGE AGREEMENT ea120625ex4-1_americanbri.htm EX-4.1 61439
3 FORM OF EXCHANGE AGREEMENT ENTERED INTO BY AND BETWEEN THE COMPANY AND THE U.S. ea120625ex10-1_americanbri.htm EX-10.1 52240
4 FORM OF EXCHANGE AGREEMENT ENTERED INTO BY AND BETWEEN THE COMPANY AND THE NON-U ea120625ex10-2_americanbri.htm EX-10.2 58423
5 PRESS RELEASE ea120625ex99-1_americanbri.htm EX-99.1 8366
  Complete submission text file 0001213900-20-009167.txt   203714
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-91436 | Film No.: 20791286
SIC: 2834 Pharmaceutical Preparations